Evidence map›Paper›PMID 20019126›Full record

ReviewMolecular endocrinology (Baltimore, Md.)2010

The Year in Neuroendocrinology.

Jeffrey D Blaustein

Open access · greenAbstract readReview
In one paragraph

Review in Molecular endocrinology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epigenetics meets endocrinology.Journal of molecular endocrinology · 2011
    Article
  5. Introduction to the year in basic science series...2009.Molecular endocrinology (Baltimore, Md.) · 2010
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jeffrey D BlausteinCenter for Neuroendocrine Studies, University of Massachusetts, Amherst, Massachusetts 01003-9271, USA. blaustein@cns.umass.edu
University of Massachusetts Amherst · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the "Year In Neuroendocrinology" session during the 2009 meeting of The Endocrine Society, I highlighted recent progress in three main areas of neuroendocrinology: neural mechanisms of action of estradiol, GnRH regulation, and epigenetics. In the area of neural mechanisms of action of estradiol, we have seen the list of estrogen receptors continue to expand and that neurosteroid synthesis is rapidly regulated by the social environment; that brain sexual differentiation can occur via the action of estradiol in upstream neurons without the need of estrogen receptors in affected neurons; and that a particular xenoestrogen can block the effects of estradiol and testosterone in brain synapses. In the area of GnRH regulation, kisspeptin continues to be a major player in reproductive endocrinology; neurokinin B should be added to the growing list of critical peptides involved in puberty and reproduction; and RFamide-related peptides have a direct role in regulation of gonadotropin-releasing neurons as a gonadotropin-inhibiting hormone. Finally, in the epigenetics field, we learned that the same principles of importance of parental care in epigenetic regulation in hippocampal glucocorticoid receptors in rats applies to humans and may explain some long-term effects of childhood abuse on the hypothalamic-pituitary-adrenal axis. It is difficult, if not impossible, to predict which findings will have an enduring impact on the field. It will be interesting to look back, 10 yr from now, to see whether the papers that were chosen were in fact well cited and whether they were influential in driving additional research in neuroendocrinology.

Indexed as

Biomedical ResearchNeuroendocrinologyAnimalsBrain ChemistryCongresses as TopicEpigenesis, GeneticEstradiolFemaleGonadotropin-Releasing HormoneHumansMaleObesityStress, PhysiologicalEstradiolGonadotropin-Releasing Hormone

Identifiers

PMID20019126
PMCPMC5428141
OpenAlexW2007464399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.